Quantcast
Recently Viewed 0 Stocks

Urovant Sciences Ltd. Quote & Summary Data

$6.8
0.15 2.16%
Delayed – 12/6/2018
  • Today's High
  • $7
  • 52 Week High
  • $ 14.32  
  • NLS Volume
  • 24,074  
  • Today's Low
  • $6.76
  • 52 Week Low
  • $ 6.65  
  • Previous Close
  • $6.8

UROV Headlines & News

Urovant Sciences Announces Participation in Piper Jaffray Healthcare Conference
Business Wire 11/19/2018 8:00:00 AM
Urovant Sciences Reports Financial Results for the Second Fiscal Quarter Ended September 30, 2018 and Provides Corporate Update
Business Wire 11/12/2018 4:05:00 PM
Urovant Sciences Completes Patient Enrollment in Phase 3 Pivotal Trial Studying Vibegron for Overactive Bladder
Business Wire 11/8/2018 8:00:00 AM
Urovant Sciences to Report 2018 Second Fiscal Quarter Financial Results
Business Wire 11/5/2018 8:00:00 AM
Urovant Sciences Announces Publication of Phase 2b Data for Vibegron in European Urology
Business Wire 11/1/2018 8:00:00 AM

Nasdaq Official Price

  • Open Price
  • $ 6.96
  • Close Price
  • $ 6.80
  • Open Date
  • Dec. 7, 2018
  • Close Date
  • Dec. 7, 2018

Real-time last five trades

NLS
Time (ET)		 NLS
Price		 NLS
Share Volume
16:00:01 6.80  1,881
15:59:05 6.80  200
15:55:36 6.80  500
15:55:30 6.80  100
15:55:18 6.80  100

Pre-market last five trades

No pre-market trades have been reported for this security.

After hours last five trades

No after hours trades have been reported for this security.